MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Holdings in Silicon Laboratories, Inc. $SLAB

Key Points

• MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Silicon Laboratories by 10.6%, now owning 57,000 shares valued at approximately $6.42 million.
• Several large investors, including Quarry LP and Parallel Advisors LLC, also acquired new positions or raised their stakes in Silicon Laboratories during the first quarter of 2023.
• Analysts have a consensus rating of "Moderate Buy" for Silicon Laboratories, with price targets ranging from $144.00 to $180.00 following recent adjustments.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 10.6% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 57,000 shares of the semiconductor company's stock after acquiring an additional 5,466 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned 0.18% of Silicon Laboratories worth $6,416,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in SLAB. Quarry LP purchased a new position in shares of Silicon Laboratories during the first quarter worth approximately $25,000. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Silicon Laboratories during the first quarter worth approximately $34,000. UMB Bank n.a. raised its stake in shares of Silicon Laboratories by 111.3% during the first quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock worth $38,000 after acquiring an additional 177 shares in the last quarter. Parallel Advisors LLC raised its stake in shares of Silicon Laboratories by 143.7% during the first quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock worth $52,000 after acquiring an additional 273 shares in the last quarter. Finally, Larson Financial Group LLC purchased a new position in shares of Silicon Laboratories during the first quarter worth approximately $55,000.

Insider Activity at Silicon Laboratories

In other news, SVP Brandon Tolany sold 1,800 shares of the business's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $133.57, for a total transaction of $240,426.00. Following the sale, the senior vice president owned 62,328 shares in the company, valued at approximately $8,325,150.96. The trade was a 2.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In the last quarter, insiders have sold 12,070 shares of company stock worth $1,703,472. Insiders own 1.60% of the company's stock.

Analyst Ratings Changes

SLAB has been the topic of several analyst reports. KeyCorp lifted their target price on shares of Silicon Laboratories from $160.00 to $180.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. Stifel Nicolaus lifted their target price on shares of Silicon Laboratories from $144.00 to $160.00 and gave the stock a "buy" rating in a research note on Friday, July 18th. Benchmark reaffirmed a "buy" rating and issued a $160.00 target price on shares of Silicon Laboratories in a research note on Tuesday, May 27th. Susquehanna lifted their target price on shares of Silicon Laboratories from $110.00 to $150.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 22nd. Finally, Morgan Stanley decreased their target price on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating on the stock in a research note on Wednesday, August 6th. Five analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $151.13.

Silicon Laboratories Trading Down 2.5%

Shares of Silicon Laboratories stock opened at $132.22 on Thursday. The company's fifty day simple moving average is $136.52 and its two-hundred day simple moving average is $126.61. The company has a market cap of $4.34 billion, a P/E ratio of -41.06 and a beta of 1.52. Silicon Laboratories, Inc. has a 12-month low of $82.82 and a 12-month high of $160.00.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, beating analysts' consensus estimates of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The firm had revenue of $192.85 million for the quarter, compared to analysts' expectations of $192.57 million. During the same quarter in the previous year, the business posted ($0.56) EPS. The company's quarterly revenue was up 32.6% on a year-over-year basis. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Analysts predict that Silicon Laboratories, Inc. will post -0.97 EPS for the current fiscal year.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.